Curis Prices $8.5 Million Private Placement
Curis announced a $8.5 million private placement priced at-the-market under Nasdaq rules with existing healthcare-focused institutional investors.
Story updates
12:01:16 PM UTC
SquawkNews
Curis priced a private placement of 16.67M shares (or pre-funded warrants) plus 16.67M common warrants for gross proceeds of ~$8.5M at $0.51 per unit; common warrants at $0.60. Certain 2026 warrants will be repriced to $0.60. Funds expected to last through initial CLL data in Dec 2026.Material Deta…
LEXINGTON, Mass., Oct. 16, 2026 // -- Curis, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into securities purch…